United States: Weekly Health Care Update - August 11, 2014

Brady Unveils Medicare/Medicaid Fraud Bill: House Ways and Means Subcommittee on Health Chairman Kevin Brady (R-TX) released a discussion draft of the Protecting Integrity Medicare Act of 2014—the Committee's expansive bill to address fraud in the Medicare and Medicaid systems. The draft, which is open for comment from stakeholders, includes a number of bipartisan priorities such as removing Social Security numbers from Medicare cards, increasing education for providers to address fraud through the Medicare Administrative Contractors, and changing durable medical equipment (DME) face-to-face requirements. Reigning in fraud and abuse in public programs continues to be a bipartisan area of agreement as lawmakers strive to introduce legislation focusing on reigning in health care spending.

Possible Litigation Threat Adds to Considerations in Containing Drug Costs: As the fight over high spending for the landmark hepatitis C drug, Sovaldi, continues to escalate, especially among state Medicaid programs, stakeholders are now concerned that lawsuits may be an emerging tactic for patients seeking access to the $84,000 per treatment drug. For example, citing a recent case in Arkansas over the cystic fibrosis drug, Kalydeco, which costs $300,000 over the course of a treatment, the Global Liver Institute is supporting the plaintiffs and indicated that more lawsuits could be on the way. The difference between the two types of drugs may be in the size of the intended population. While there are 3.2 million Americans with hepatitis C and clinicians continue to argue about the effectiveness of Sovaldi for a large subset of the group, the entire cystic fibrosis population numbers around 30,000 in the U.S. For many policymakers in the states and at the federal level, the debate continues around the likelihood for which any innovative therapy is likely to reduce costs/improve quality for a patient and whether that can justify the up-front price of a particular drug.

Implementation of the Affordable Care Act

HHS Awards State Home Visiting Grants: Health and Human Services (HHS) Secretary Burwell announced $106.7 million in FY 2014 grants, awarded to 46 states and jurisdictions. The awards, part of the Maternal, Infant, and Early Childhood Home Visiting Program (Home Visiting Program) established by the ACA, help states expand home visiting services.

Stage 2 Outlook Improving: According to an update from Centers for Medicare & Medicaid Services (CMS), Stage 2 meaningful use attestations were up through August. As of the end of July, 78 hospitals and 1,898 professionals have met Stage 2 requirements.

HHS Lacks Emails Subpoenaed by Oversight Committee: HHS sent House Oversight Committee Chairman Darrell Issa (R-CA) and Ranking Member Elijah Cumming (D-MD) a letter notifying them that the agency may not be able to provide all the emails regarding the Healthcare.gov rollout that the Chairman subpoenaed.

CMS' Open Payment System Goes Offline to Undergo Fixes: CMS announced that it will temporarily take down its Open Payment system to complete needed repairs. The news is a win for drug and medical equipment manufacturers. They had earlier requested CMS to extend the deadline so that they can comply with the system's mandate for manufacturers to report information to CMS regarding payments made to doctors and teaching hospitals.

Other Federal Regulatory Initiatives

HHS Holding Telehealth Committee Meeting: The National Advisory Committee on Rural Health and Human Services published a notice stating that it would be meeting on September 24th in Sioux Falls to discuss telehealth coverage opportunities created by the ACA.

CDC Moved to Emergency Ops: Director Tom Frieden announced that the CDC's Emergency Operations Center has elevated to Level 1 activity—the agency's highest response level—in response to the Ebola outbreak.

CMS Announces EHR Use Up: CMS released CDC data showing that EHR adoption among health care providers is up from previous years. Citing studies published in Health Affairs, CMS states that in 2013 78 percent of office-based physicians reported they use some sort of EHR system.

New Region II HHS Director Appointed: Secretary Burwell announced the appointment of Jackie Cornell-Bechelli as Region II Director of HHS. The Region II office is based in New York City, and works with officials in New York, New Jersey, Puerto Rico, and the U.S. Virgin Islands.

ONC Announces New Policy Committees: The Office of the National Coordinator for Health IT (ONC) announced the efforts of a realignment across health IT. The streamlining resulted in the creation of a new Health IT Policy and Standards Committees.

ONC Outlines Interoperability Plan: In a blog post, the ONC outlined its 10 year vision for interoperability. The agency plans to develop a version 1.0 of a nationwide interoperability map over the next year. The roadmap will outline how to achieve the 3, 6, and 10 year interoperability milestones described in the paper.

CMS Restarting RAC Program: CMS announced that it will restart the Recovery Audit Program. Recovery Audit Contractors will resume work in August to review improper payment claims in the Medicare program.

FDA Releases Biologic Exclusivity Guidance: The FDA released guidance for biologic sponsors to help the agency determine when exclusivity starts for products. Reference biologics receive 12 years of exclusivity.

Community Health Systems Settles with DOJ: Community Health Systems, Inc., the largest acute care hospital operator, settled with the Department of Justice for $98.15 million to resolve allegations that the company's hospitals billed Medicare for inpatient services improperly.

Other Congressional and State Initiatives

Senators Write Burwell on Biosimilars: Senators Lamar Alexander (R-TN) and Orrin Hatch (R-UT) wrote to Secretary Burwell requesting HHS "immediately release" guidance on biosimilars. The lawmakers argue that, although the FDA has already accepted a biosimilars application for review, it has not released any guidance.

Lawmakers Prod FCC on Rural Broadband: Nine Members of the House wrote to FCC Chairman Tom Wheeler expressing concern over eligibility for the Healthcare Connect Fund program, which subsidizes broadband for rural health providers.

Democrats Push for E-Cig Protections: Thirteen Senate and House Democrats wrote to FDA Commissioner Margaret Hamburg asking the agency to use existing authority to protect children from predatory e-cig marketing and tactics.

Rep. Bilirakis Hosting 21st Century Roundtable: As part of the House Energy and Commerce's 21st Century Cures Initiative, Representative Gus Bilirakis (R-FL) will hold two roundtables in Florida. The first roundtable on August 19th will focus on Patients and the Patient Perspectives and the second on August 22nd will focus on Spurring Innovation, Advancing Treatments, and Incentivizing Investment.

House Subcommittee Convenes for Ebola Hearing: The House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations met for an August hearing to examine the international response to the Ebola outbreak.

Upcoming Congressional Hearings and Markups

The Senate and House are in Recess.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Andrew J. Shin
Abby Matousek
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions